Literature DB >> 23676481

Changes in sex and non-sex hormones and distribution of erythrocyte antigens in reproductive age women with tumors of body of uterus in Adjara.

I Nakashidze1, N Kotrikadze, A Diasamidze, M Nagervadze, L Ramishvili.   

Abstract

The aim the research was to study the hormonal state of reproductive age women with tumors of body of uterus. The quantitative changes of sex steroid hormones: progesterone (P), estradiol (E), testosterone (T), gonadotropine -Luteinizing hormone (LH) and Follicle-stimulating hormone (FSH) were investigated. Distribution of ABO blood group antigens and Rh-Hr systems genetic variants in the blood of women living in Adjara Region was also studied. For study was used reproductive age women's blood with benign (fibromioma) and malignant (endometrial cancer) tumors of body of uterus (the middle age was 20-45 years). The determination of hormones was made by the enzymatic analysis method (ELAIZA). For the research of blood groups, were used the immunoserologic methods. The study have revealed that in blood of reproductive age women with benign and malignant tumors of body of uterus, level of estradiol was increased while levels of progesterone and testosterone were sharply reduced. Amount of Follicle-stimulating hormone and Luteinizing hormone were also increased. It's significant that, both hormones were sharply increased in case of cancer of body of uterus, in comparison with control group and benign tumor. According to distribution of ABO blood group phenotypes - O (I) phenotypic group of ABO system has its highest frequency in blood of women with cancer of body of uterus. Cancer of body of uterus is associated with O (I) phenotypic groups; benign tumor of body of uterus - with A(II) and AB(IV) phenotypic groups. Women with cc and EE genetic variants of Rh-Hr system have sensitivity to the development of benign and malignant tumors of body of uterus; women with ee genetic variant have lower sensitivity towards body of uterus cancer and sharply expressed sensitivity to uterus benign tumors. In women with malignant tumors of body of uterus the frequency of distribution of Rh-Hr system CC genetic variant was sharply reduced.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23676481

Source DB:  PubMed          Journal:  Georgian Med News        ISSN: 1512-0112


  2 in total

1.  Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.

Authors:  Georgios Gitas; Louisa Proppe; Ibrahim Alkatout; Dimitrios Tsolakidis; Achim Rody; Christos Kotanidis; Sascha Baum
Journal:  Blood Transfus       Date:  2020-06-04       Impact factor: 3.443

2.  ABO Blood Group and Endometrial Carcinoma: A Preliminary Single-Center Experience from Saudi Arabia.

Authors:  Ahmed Abu-Zaid; Mohannad Alsabban; Mohammed Abuzaid; Osama Alomar; Ismail A Al-Badawi; Hany Salem
Journal:  Cureus       Date:  2017-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.